Temsirolimus Side Effects|
|
Did You Have a Temsirolimus Side Effect? How Effective is Temsirolimus for You? |
Temsirolimus Forum |
Temsirolimus Adverse Effect Reports (FDA)
Showing 1-25 of 1065 Next Page >
Cough, Snoring, Blood Ph Decreased, Hypercapnia, Dyspnoea, Forced Expiratory Volume Decreased, Pco2 Increased, Blood Bicarbonate Increased (8482963-0)
on Jun 18, 2012 Female patient from UNITED STATES , 15 years of age, weighting 116.4 lb, was diagnosed with
Patient was taking other medications:
Humerus Fracture (8475894-3)
Patient was taking Temsirolimus (View Usage). Patient had the following side effects: humerus fracture on Jun 21, 2012 from JAPAN Additional patient health information: Female patient , 78 years of age, weighting 132.3 lb, was diagnosed with
Patient was taking other medications:
Stomatitis, Platelet Count Decreased (8470674-7)
Adverse event was reported on Jun 20, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 15 Mg, Unk) was diagnosed with
Patient was taking other medications:
Pneumothorax, Pleuritic Pain, Dyspnoea (8468179-2)
on Jun 15, 2012 Female patient from UNITED STATES , weighting 126.1 lb, was diagnosed with
Patient was taking other medications:
Osteonecrosis, Cluster Headache, Pelvic Pain, Diabetes Mellitus, Arthralgia (8459433-9)
on Jun 18, 2012 Male patient from CANADA , weighting 211.6 lb, was diagnosed with
Patient was taking other medications:
Sinusitis (8454081-9)
Patient was taking Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: sinusitis (sinusitis Questions) on Jun 13, 2012 from POLAND Additional patient health information: Male patient , 57 years of age, . Temsirolimus dosage: 25 Mg, Unk. Patient was hospitalized.
Dyspnoea, Atrial Fibrillation, Fatigue, Renal Failure Acute, Urinary Tract Infection (8447610-2)
Adverse event was reported on Jun 08, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 25 Mg, Weekly) was diagnosed with
Patient was taking other medications:
Anal Ulcer (8439668-1)
on Jun 06, 2012 Male patient from UNITED STATES , child 10 years of age, weighting 109.3 lb, was diagnosed with
Patient was taking other medications:
Dyspnoea, Renal Failure Acute, Urinary Tract Infection, Atrial Fibrillation, Fatigue (8437234-5)
on Jun 08, 2012 Male patient from UNITED STATES , weighting 225.1 lb, was diagnosed with
Patient was taking other medications:
Atelectasis, Febrile Neutropenia, Pneumonitis, Hypokalaemia, Pleural Effusion, Hypotension, Hypoxia (8429018-9)
Patient was taking Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: atelectasis, febrile neutropenia, pneumonitis, hypokalaemia, pleural effusion, hypotension, hypoxia on Jun 07, 2012 from UNITED STATES Additional patient health information: Female patient , 14 years of age, weighting 121.3 lb, was diagnosed with
Patient was taking other medications:
Atrial Fibrillation, Fatigue, Renal Failure Acute, Dyspnoea, Urinary Tract Infection (8423599-7)
Adverse event was reported on Jun 01, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 25 Mg, Weekly) was diagnosed with
Patient was taking other medications:
Depressed Level Of Consciousness (8421528-3)
on May 16, 2012 Male patient from FRANCE , 74 years of age, was diagnosed with
Patient was taking other medications:
Hypoxia (8420885-1)
on Jun 04, 2012 Female patient from JAPAN , 64 years of age, weighting 110.2 lb, was diagnosed with
Patient was taking other medications:
Pneumonitis, Atelectasis, Febrile Neutropenia, Hypoxia, Hypotension, Hypokalaemia, Pleural Effusion (8419951-6)
Patient was taking Temsirolimus (View Usage). Patient had the following side effects: pneumonitis, atelectasis, febrile neutropenia, hypoxia, hypotension, hypokalaemia, pleural effusion on May 30, 2012 from UNITED STATES Additional patient health information: Female patient , 14 years of age, weighting 121.3 lb, was diagnosed with
Patient was taking other medications:
Disease Progression, Renal Cell Carcinoma (8418669-3)
Adverse event was reported on Jun 05, 2012 by a Female patient taking Temsirolimus (View Usage) (Dosage: 25 Mg, Weekly) . Location: JAPAN , 62 years of age, weighting 90.39 lb, After Temsirolimus was administered, patient had the following side effects: disease progression, renal cell carcinoma.
Urinary Tract Infection, Dyspnoea, Renal Failure Acute, Atrial Fibrillation, Fatigue (8414925-3)
on Jun 01, 2012 Male patient from UNITED STATES , 66 years of age, weighting 224.0 lb, was diagnosed with
Patient was taking other medications:
Pneumocystis Jiroveci Pneumonia (8406933-3)
on Jun 04, 2012 Male patient from JAPAN , 57 years of age, was diagnosed with
Systemic Inflammatory Response Syndrome, Rash (8404730-6)
Patient was taking Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: systemic inflammatory response syndrome, rash (rash Questions) on May 31, 2012 from SWITZERLAND Additional patient health information: Male patient , 55 years of age, weighting 220.5 lb, was diagnosed with
Patient was taking other medications:
Pneumonia Bacterial, Interstitial Lung Disease (8402001-5)
Adverse event was reported on May 30, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 25 Mg, Unk) . Location: JAPAN , 68 years of age, weighting 79.37 lb, Patient experienced the following unwanted or unexpected effects: pneumonia bacterial, interstitial lung disease.
Patient was taking other medications:
Pulmonary Embolism, Deep Vein Thrombosis, Pneumothorax (8401938-0)
on May 24, 2012 Male patient from GERMANY , weighting 176.4 lb, was diagnosed with
Patient was taking other medications:
Sinusitis (8396496-3)
on May 28, 2012 Male patient from POLAND , 57 years of age, was treated with Temsirolimus(View Usage). After Temsirolimus was administered, patient had the following side effects: sinusitis (sinusitis Questions). Temsirolimus dosage: 50 Mg, Unk. Patient was hospitalized.
Cardiac Arrest (8396483-5)
Patient was taking Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (cardiac arrest Questions) on May 22, 2012 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 110.0 lb, . Temsirolimus dosage: 20 Mg, On Days 1,8, 15, 22 Of Each 28 Days Cycle.
Patient was taking other medications:
Dyspnoea (8395290-7)
Adverse event was reported on May 24, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 12.5 Mg, Unk) . Location: JAPAN , 83 years of age, weighting 132.3 lb, Patient had the following side effects: dyspnoea.
Patient was taking other medications:
Decreased Appetite, Weight Decreased, Nausea, Sepsis, Dyspnoea, Ascites (8392985-6)
on May 23, 2012 Male patient from GERMANY , 60 years of age, weighting 152.1 lb, was diagnosed with
Patient was taking other medications:
Hyperlipidaemia, Interstitial Lung Disease, Dyspnoea, Renal Impairment, Anaemia (8384733-0)
on May 15, 2012 Male patient from TAIWAN, PROVINCE OF CHINA , 57 years of age, was diagnosed with
on Jun 18, 2012 Female patient from UNITED STATES , 15 years of age, weighting 116.4 lb, was diagnosed with
- lymphoma (lymphoma Questions)
Patient was taking other medications:
- IRINOTECAN HYDROCHLORIDE (90 Mg/m2, Po) (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label )
- TEMOZOLOMIDE (100 Mg/m2, Po) (View Temozolomide Review and Temozolomide Label )
Humerus Fracture (8475894-3)
Patient was taking Temsirolimus (View Usage). Patient had the following side effects: humerus fracture on Jun 21, 2012 from JAPAN Additional patient health information: Female patient , 78 years of age, weighting 132.3 lb, was diagnosed with
- metastatic renal cell carcinoma
Patient was taking other medications:
- AMLODIPINE (5 Mg, 1x/day) (View Amlodipine Review and Amlodipine Label )
- ADALAT (20 Mg, 1x/day) (View Adalat Review and Adalat Label )
- TALION (20 Mg, 1x/day) (View Talion Review and Talion Label )
- CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (Unk) (View Candesartan Cilexetil And Hydrochlorothiazide Review and Candesartan Cilexetil And Hydrochlorothiazide Label )
- ALLOPURINOL (300 Mg, 1x/day) (View Allopurinol Review and Allopurinol Label )
Stomatitis, Platelet Count Decreased (8470674-7)
Adverse event was reported on Jun 20, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 15 Mg, Unk) was diagnosed with
- metastatic renal cell carcinoma
- prophylaxis
Patient was taking other medications:
- POLARAMINE (5 Mg, Weekly) (View Polaramine Review and Polaramine Label )
- FERROUS CITRATE (Unk) (View Ferrous Citrate Review and Ferrous Citrate Label )
- LASIX (20 Mg, 1x/day) (View Lasix Review and Lasix Label )
- FAMOTIDINE (20 Mg, 1x/day) (View Famotidine Review and Famotidine Label )
Pneumothorax, Pleuritic Pain, Dyspnoea (8468179-2)
on Jun 15, 2012 Female patient from UNITED STATES , weighting 126.1 lb, was diagnosed with
- renal cell carcinoma
Patient was taking other medications:
- ATIVAN (View Ativan Review and Ativan Label )
- UREA CREAM (View Urea Cream Review and Urea Cream Label )
- BACTRIM (View Bactrim Review and Bactrim Label )
- LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label )
- OMEPRAZOLE (View Omeprazole Review and Omeprazole Label )
- ZOFRAN (View Zofran Review and Zofran Label )
- ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label )
- AVASTIN (View Avastin Review and Avastin Label )
Osteonecrosis, Cluster Headache, Pelvic Pain, Diabetes Mellitus, Arthralgia (8459433-9)
on Jun 18, 2012 Male patient from CANADA , weighting 211.6 lb, was diagnosed with
- metastatic renal cell carcinoma
Patient was taking other medications:
- FERROUS SULFATE TAB (1 Df, 1x/day) (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label )
- ASPIRIN (325 Mg, 1x/day) (View Aspirin Review and Aspirin Label )
- METFORMIN (500 Mg, 1x/day) (View Metformin Review and Metformin Label )
- NORVASC (5 Mg, 1x/day) (View Norvasc Review and Norvasc Label )
- ZOPICLONE (7.5 Mg, 1x/day At Bedtime) (View Zopiclone Review and Zopiclone Label )
- CRESTOR (10 Mg, 1x/day) (View Crestor Review and Crestor Label )
- SYNTHROID (100 Ug, 1x/day) (View Synthroid Review and Synthroid Label )
- FENOFIBRATE (200 Mg, 1x/day) (View Fenofibrate Review and Fenofibrate Label )
Sinusitis (8454081-9)
Patient was taking Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: sinusitis (sinusitis Questions) on Jun 13, 2012 from POLAND Additional patient health information: Male patient , 57 years of age, . Temsirolimus dosage: 25 Mg, Unk. Patient was hospitalized.
Dyspnoea, Atrial Fibrillation, Fatigue, Renal Failure Acute, Urinary Tract Infection (8447610-2)
Adverse event was reported on Jun 08, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 25 Mg, Weekly) was diagnosed with
- mantle cell lymphoma
Patient was taking other medications:
- VELCADE (1.6 Mg/m2, Weekly) (View Velcade Review and Velcade Label )
Anal Ulcer (8439668-1)
on Jun 06, 2012 Male patient from UNITED STATES , child 10 years of age, weighting 109.3 lb, was diagnosed with
- b precursor type acute leukaemia
Patient was taking other medications:
- DEXAMETHASONE SODIUM PHOSPHATE (10 Mg/m2/ Dose Po Bid Or Iv On Days 1-5 And 15-19.) (View Dexamethasone Sodium Phosphate Review and Dexamethasone Sodium Phosphate Label )
- PEG ASPARAGINASE (2500 Iu/m2, Over 1 Hour On Days 3 And 17 Or ((if Allergic To Pegaspargase Use Erwinia Asparaginase)) (View Peg-asparaginase Review and Peg-asparaginase Label )
- METHOTREXATE (8-15mg (age Based Dosing) It On Days 1 (or Up To 72 Hours Prior To Day 1) And 8) (View Methotrexate Review and Methotrexate Label )
- VINCRISTINE SULFATE (1.5 Mg/m2 (max 2 Mg), Push Over 1-5 Minutes Or Infusion Via Minibag On Days 1,8,15,22.) (View Vincristine Sulfate Review and Vincristine Sulfate Label )
- MITOXANTRONE HYDROCHLORIDE (10 Mg/m2 Iv Over 30 Minutes On Days 1 And 2, And) (View Mitoxantrone Hydrochloride Review and Mitoxantrone Hydrochloride Label )
Dyspnoea, Renal Failure Acute, Urinary Tract Infection, Atrial Fibrillation, Fatigue (8437234-5)
on Jun 08, 2012 Male patient from UNITED STATES , weighting 225.1 lb, was diagnosed with
- mantle cell lymphoma
Patient was taking other medications:
- VELCADE (1.6 Mg/m2, Weekly) (View Velcade Review and Velcade Label )
Atelectasis, Febrile Neutropenia, Pneumonitis, Hypokalaemia, Pleural Effusion, Hypotension, Hypoxia (8429018-9)
Patient was taking Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: atelectasis, febrile neutropenia, pneumonitis, hypokalaemia, pleural effusion, hypotension, hypoxia on Jun 07, 2012 from UNITED STATES Additional patient health information: Female patient , 14 years of age, weighting 121.3 lb, was diagnosed with
- rhabdomyosarcoma
Patient was taking other medications:
- CYCLOPHOSPHAMIDE (1200mg/m2, Over 30-60 Minutes On Day 1) (View Cyclophosphamide Review and Cyclophosphamide Label )
- VINORELBINE (25 Mg/m2, Over 6-10 Minutes On Days 1 And 8) (View Vinorelbine Review and Vinorelbine Label )
Atrial Fibrillation, Fatigue, Renal Failure Acute, Dyspnoea, Urinary Tract Infection (8423599-7)
Adverse event was reported on Jun 01, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 25 Mg, Weekly) was diagnosed with
- mantle cell lymphoma
Patient was taking other medications:
- VELCADE (1.6 Mg/m2, Weekly) (View Velcade Review and Velcade Label )
Depressed Level Of Consciousness (8421528-3)
on May 16, 2012 Male patient from FRANCE , 74 years of age, was diagnosed with
- glioblastoma
Patient was taking other medications:
- ESCITALOPRAM (View Escitalopram Review and Escitalopram Label )
- PREDNISOLONE (View Prednisolone Review and Prednisolone Label )
- ONFI (5 Mg Milligram(s), Oral) (View Onfi Review and Onfi Label )
- KEPPRA (View Keppra Review and Keppra Label )
- RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label )
Hypoxia (8420885-1)
on Jun 04, 2012 Female patient from JAPAN , 64 years of age, weighting 110.2 lb, was diagnosed with
- renal cell carcinoma
Patient was taking other medications:
- RESTAMIN (50 Mg, Weekly) (View Restamin Review and Restamin Label )
Pneumonitis, Atelectasis, Febrile Neutropenia, Hypoxia, Hypotension, Hypokalaemia, Pleural Effusion (8419951-6)
Patient was taking Temsirolimus (View Usage). Patient had the following side effects: pneumonitis, atelectasis, febrile neutropenia, hypoxia, hypotension, hypokalaemia, pleural effusion on May 30, 2012 from UNITED STATES Additional patient health information: Female patient , 14 years of age, weighting 121.3 lb, was diagnosed with
- rhabdomyosarcoma
Patient was taking other medications:
- CYCLOPHOSPHAMIDE (Day 1 Over 30-60 Minutes) (View Cyclophosphamide Review and Cyclophosphamide Label )
- NAVELBINE (Days 1 And 8, Over 6-10 Minutes) (View Navelbine Review and Navelbine Label )
Disease Progression, Renal Cell Carcinoma (8418669-3)
Adverse event was reported on Jun 05, 2012 by a Female patient taking Temsirolimus (View Usage) (Dosage: 25 Mg, Weekly) . Location: JAPAN , 62 years of age, weighting 90.39 lb, After Temsirolimus was administered, patient had the following side effects: disease progression, renal cell carcinoma.
Urinary Tract Infection, Dyspnoea, Renal Failure Acute, Atrial Fibrillation, Fatigue (8414925-3)
on Jun 01, 2012 Male patient from UNITED STATES , 66 years of age, weighting 224.0 lb, was diagnosed with
- mantle cell lymphoma
Patient was taking other medications:
- VELCADE (1.6mg/m2 Weekly Iv Drip) (View Velcade Review and Velcade Label )
Pneumocystis Jiroveci Pneumonia (8406933-3)
on Jun 04, 2012 Male patient from JAPAN , 57 years of age, was diagnosed with
- metastatic renal cell carcinoma
Systemic Inflammatory Response Syndrome, Rash (8404730-6)
Patient was taking Temsirolimus (View Usage). After Temsirolimus was administered, patient had the following side effects: systemic inflammatory response syndrome, rash (rash Questions) on May 31, 2012 from SWITZERLAND Additional patient health information: Male patient , 55 years of age, weighting 220.5 lb, was diagnosed with
- glioblastoma
Patient was taking other medications:
- CLEMASTINE FUMARATE (2 Mg, Weekly) (View Clemastine Fumarate Review and Clemastine Fumarate Label )
Pneumonia Bacterial, Interstitial Lung Disease (8402001-5)
Adverse event was reported on May 30, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 25 Mg, Unk) . Location: JAPAN , 68 years of age, weighting 79.37 lb, Patient experienced the following unwanted or unexpected effects: pneumonia bacterial, interstitial lung disease.
Patient was taking other medications:
- REBAMIPIDE (100 Mg, 2x/day) (View Rebamipide Review and Rebamipide Label )
- LORFENAMIN (60 Mg, 2x/day) (View Lorfenamin Review and Lorfenamin Label )
- CHLOR TRIMETON (10 Mg, Unk) (View Chlor-trimeton Review and Chlor-trimeton Label )
Pulmonary Embolism, Deep Vein Thrombosis, Pneumothorax (8401938-0)
on May 24, 2012 Male patient from GERMANY , weighting 176.4 lb, was diagnosed with
- metastatic renal cell carcinoma
Patient was taking other medications:
- AFINITOR (10 Mg, 1x/day) (View Afinitor Review and Afinitor Label )
- PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label )
Sinusitis (8396496-3)
on May 28, 2012 Male patient from POLAND , 57 years of age, was treated with Temsirolimus(View Usage). After Temsirolimus was administered, patient had the following side effects: sinusitis (sinusitis Questions). Temsirolimus dosage: 50 Mg, Unk. Patient was hospitalized.
Cardiac Arrest (8396483-5)
Patient was taking Temsirolimus (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (cardiac arrest Questions) on May 22, 2012 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 110.0 lb, . Temsirolimus dosage: 20 Mg, On Days 1,8, 15, 22 Of Each 28 Days Cycle.
Patient was taking other medications:
- POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label )
- ZOLPIDEM (View Zolpidem Review and Zolpidem Label )
- MORPHINE (View Morphine Review and Morphine Label )
Dyspnoea (8395290-7)
Adverse event was reported on May 24, 2012 by a Male patient taking Temsirolimus (View Usage) (Dosage: 12.5 Mg, Unk) . Location: JAPAN , 83 years of age, weighting 132.3 lb, Patient had the following side effects: dyspnoea.
Patient was taking other medications:
- POLYCARBOPHIL CALCIUM (1 G, 3x/day) (View Polycarbophil Calcium Review and Polycarbophil Calcium Label )
- TRAMADOL HYDROCHLORIDE (25 Mg, 4x/day) (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label )
- OXINORM (5 Mg, As Needed) (View Oxinorm Review and Oxinorm Label )
- CHLOR TRIMETON (10 Mg, 1x/day) (View Chlor-trimeton Review and Chlor-trimeton Label )
- MAGNESIUM OXIDE (0.5 G, 3x/day) (View Magnesium Oxide Review and Magnesium Oxide Label )
- ALOSENN (0.5 G, 3x/day) (View Alosenn Review and Alosenn Label )
Decreased Appetite, Weight Decreased, Nausea, Sepsis, Dyspnoea, Ascites (8392985-6)
on May 23, 2012 Male patient from GERMANY , 60 years of age, weighting 152.1 lb, was diagnosed with
- renal cancer
Patient was taking other medications:
- MCP ^ALIUD PHARMA^ (View Mcp ^aliud Pharma^ Review and Mcp ^aliud Pharma^ Label )
- ATACAND (View Atacand Review and Atacand Label )
- AMLODIPINE (View Amlodipine Review and Amlodipine Label )
- DEXAMETHASONE (4 Mg, Unk) (View Dexamethasone Review and Dexamethasone Label )
- PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label )
- TORSEMIDE (View Torsemide Review and Torsemide Label )
- DIPYRONE TAB (View Dipyrone Tab Review and Dipyrone Tab Label )
- SEROQUEL (View Seroquel Review and Seroquel Label )
Hyperlipidaemia, Interstitial Lung Disease, Dyspnoea, Renal Impairment, Anaemia (8384733-0)
on May 15, 2012 Male patient from TAIWAN, PROVINCE OF CHINA , 57 years of age, was diagnosed with
- metastatic renal cell carcinoma
Showing 1-25 of 1065 Next Page >
Share Your Experience, Discuss with Others
Temsirolimus InformationSide Effects reported to FDA: 1065. View FDA Adverse Reports Temsirolimus safety alerts: No Reported deaths: 238 Reported hospitalizations: 776
| ||||